Novel treatments to help patients with central nervous system disorders


  • 2017-04-04
    BioArctic receives a grant from Vinnova/Medtech4Health for its quality management system work
    Read more »
  • 2017-03-21
    - BioArctic to present two posters at the International Conference on Alzheimer’s and Parkinson’s Diseases
    Read more »
  • 2017-03-16
    - BioArctic receives a grant of half a million SEK from Vinnova for a collaborative research project concerning commercial potential of antibody-based PET imaging
    Read more »



Antibodies targeting toxic proteins



First drug candidate in development for Alzheimer’s disease

Therapeutic Area


CNS disorders

April – the Month of Parkinson’s Disease Awareness

April 11 is the World Parkinson’s Disease Day and marks the birthday of Dr. J Parkinson who first described the disease in “An Essay on the Shaking Palsy” 200 years ago. The month of April is dedicated to raise awareness of the Parkinson’s disease.

Gunilla Osswald, CEO: “With patients in mind, we strive to transform the treatment regimen of a neurodegenerative disease like Parkinson’s disease. Together with our partner AbbVie we are truly committed to do our outmost to bring an innovative disease modifying treatment to the large number of patients suffering from Parkinson’s disease.”

Read more »

Proud partner of